Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study)

ClinicalTrials.gov ID: NCT05648110

Public ClinicalTrials.gov record NCT05648110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/III Randomized, Double-blind Study to Evaluate the Safety, Efficacy and Neutralizing Activity of AZD5156/AZD3152 for Pre-exposure Prophylaxis of COVID-19 in Participants With Conditions Causing Immune Impairment. Sub-study: Phase II Open Label Sub-study to Evaluate the Safety, PK, and Neutralizing Activity of AZD3152 for Pre-exposure Prophylaxis of COVID-19

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

AZD3152, a single mAb, is being developed to have broad neutralizing activity across known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19. The aim of the Phase I/III study (Parent Study) will be to evaluate the safety, efficacy and neutralizing activity of AZD3152 compared with comparator for pre exposure prophylaxis of COVID-19, and separately evaluate the safety and PK of AZD5156, a combination of AZD3152 and AZD1061. Sub-study: This Phase II sub-study of SUPERNOVA will assess the safety, PK, and predicted neutralizing activity of AZD3152 compared with EVUSHELD for pre-exposure prophylaxis of COVID-19.

Study identification

NCT ID
NCT05648110
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
3,882 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years to 130 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 16, 2022 (Actual)
Primary completion
Mar 29, 2024 (Actual)
Completion
Feb 11, 2025 (Actual)
Last update posted
Jun 18, 2026

2022 – 2025

United States locations

U.S. sites
130
U.S. states
39
U.S. cities
111
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209 —
Research Site Birmingham Alabama 35215 —
Research Site Mobile Alabama 36608 —
Research Site Glendale Arizona 85306 —
Research Site Mesa Arizona 85206 —
Research Site Mesa Arizona 85210 —
Research Site Tucson Arizona 85712 —
Research Site Little Rock Arkansas 72205 —
Research Site Colton California 92324 —
Research Site La Mesa California 91942 —
Research Site Long Beach California 90815 —
Research Site Los Angeles California 90027 —
Research Site Modesto California 95350 —
Research Site Sacramento California 95817 —
Research Site Tustin California 92780 —
Research Site Westminster California 92683 —
Research Site Aurora Colorado 80014 —
Research Site Denver Colorado 80209 —
Research Site Denver Colorado 80246 —
Research Site Fort Collins Colorado 80525 —
Research Site New Haven Connecticut 06519 —
Research Site Washington D.C. District of Columbia 20007 —
Research Site Coral Gables Florida 33134 —
Research Site Fleming Island Florida 32003 —
Research Site Fort Myers Florida 33912 —
Research Site Hollywood Florida 33024 —
Research Site Jacksonville Florida 32216 —
Research Site Jacksonville Florida 32256 —
Research Site Lake Worth Florida 33462 —
Research Site Largo Florida 33777 —
Research Site Lauderdale Lakes Florida 33313 —
Research Site Leesburg Florida 34748 —
Research Site Medley Florida 33166 —
Research Site Miami Florida 33125 —
Research Site Miami Florida 33126 —
Research Site Miami Florida 33135 —
Research Site Miami Florida 33186 —
Research Site Miami Lakes Florida 33014 —
Research Site Miami Springs Florida 33166 —
Research Site North Miami Beach Florida 33162 —
Research Site Orlando Florida 32806 —
Research Site Ormond Beach Florida 32174 —
Research Site Port Orange Florida 32127 —
Research Site St. Petersburg Florida 33713 —
Research Site Winter Park Florida 32789 —
Research Site Atlanta Georgia 30342 —
Research Site Columbus Georgia 31904 —
Research Site Boise Idaho 83712 —
Research Site Burr Ridge Illinois 60527 —
Research Site Chicago Illinois 60612 —
Research Site Chicago Illinois 60640 —
Research Site Gurnee Illinois 60031 —
Research Site Evansville Indiana 47712 —
Research Site Evansville Indiana 47715 —
Research Site South Bend Indiana 46617 —
Research Site West Des Moines Iowa 50266 —
Research Site Overland Park Kansas 66204 —
Research Site Wichita Kansas 67214 —
Research Site Bowling Green Kentucky 42101 —
Research Site Lexington Kentucky 40503 —
Research Site Lexington Kentucky 40509 —
Research Site Lake Charles Louisiana 70605 —
Research Site Metairie Louisiana 70006 —
Research Site New Orleans Louisiana 70119 —
Research Site Baltimore Maryland 21287 —
Research Site Boston Massachusetts 02115 —
Research Site Boston Massachusetts 02215 —
Research Site Methuen Massachusetts 01844 —
Research Site Springfield Massachusetts 01107 —
Research Site Worcester Massachusetts 01655 —
Research Site Detroit Michigan 48202 —
Research Site Farmington Hills Michigan 48334 —
Research Site Grand Rapids Michigan 49525 —
Research Site Novi Michigan 48377 —
Research Site Saint Clair Shores Michigan 48081 —
Research Site Minneapolis Minnesota 55446 —
Research Site Jefferson City Missouri 65109 —
Research Site Kansas City Missouri 64114 —
Research Site St Louis Missouri 63110 —
Research Site St Louis Missouri 63131 —
Research Site Missoula Montana 59808 —
Research Site Lincoln Nebraska 68516 —
Research Site Las Vegas Nevada 89119 —
Research Site Portsmouth New Hampshire 03801 —
Research Site Hackensack New Jersey 07601 —
Research Site Albuquerque New Mexico 87109 —
Research Site Buffalo New York 14202 —
Research Site Ridgewood New York 11385 —
Research Site Rochester New York 14607 —
Research Site Rochester New York 14642 —
Research Site Charlotte North Carolina 28208 —
Research Site Durham North Carolina 27710 —
Research Site Monroe North Carolina 28112 —
Research Site Morehead City North Carolina 28557 —
Research Site Wilmington North Carolina 28403 —
Research Site Cincinnati Ohio 45267 —
Research Site Westlake Ohio 44145 —
Research Site Allentown Pennsylvania 18103 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Harrisburg Pennsylvania 17110 —
Research Site Philadelphia Pennsylvania 19104 —
Research Site Philadelphia Pennsylvania 19107 —
Research Site Pittsburgh Pennsylvania 15232 —
Research Site Providence Rhode Island 02903 —
Research Site Myrtle Beach South Carolina 29572 —
Research Site North Charleston South Carolina 29405 —
Research Site Rock Hill South Carolina 29732 —
Research Site Spartanburg South Carolina 29303 —
Research Site Knoxville Tennessee 37909 —
Research Site Austin Texas 78745 —
Research Site Dallas Texas 75246 —
Research Site El Paso Texas 79925 —
Research Site Houston Texas 77054 —
Research Site Houston Texas 77065 —
Research Site Houston Texas 77070 —
Research Site Houston Texas 77081 —
Research Site Houston Texas 77089 —
Research Site Kingwood Texas 77339 —
Research Site Mesquite Texas 75150 —
Research Site San Angelo Texas 76904 —
Research Site San Antonio Texas 78229 —
Research Site Shenandoah Texas 77384 —
Research Site Layton Utah 84041 —
Research Site Salt Lake City Utah 84115 —
Research Site Annandale Virginia 22003 —
Research Site Norfolk Virginia 23502 —
Research Site Norfolk Virginia 23507 —
Research Site Olympia Washington 98506 —
Research Site Seattle Washington 98109 —
Research Site Madison Wisconsin 53715 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05648110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05648110 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →